Institutional Review Board, Hospital for Special Surgery
The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.
For further information, see Understanding Clinical Trials.
John. P. DiFiori, MD, FACSM, FAMSSM
James J. Kinderknecht, MD
Robert G. Marx, MD
Andrew D. Pearle, MD
James Russomano, MS, CSCS
Riley J. Williams III, MD
The purpose of this survey study is to help inform the development of an education-based youth basketball injury prevention program. In addition to collecting non-identifying demographic information from youth basketball coaches, this survey assesses knowledge, perceptions, confidence, and opinions related to sports injury prevention and injury risk management concepts and principles.
This survey is open to youth basketball coaches affiliated with the Jr. NBA. All coaches must be 18 years or older.